ROBO-PAWS: Robot-Dog-Assisted Walking

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-7
SponsorKoç University

About this trial

Childhood cancers affect approximately 400,000 children and adolescents worldwide each year. Although advances in treatment have significantly improved survival rates, children undergoing cancer treatment continue to experience a wide range of treatment-related symptoms and complications. Among these, fatigue and sleep disturbances are particularly common and may persist throughout treatment and survivorship, negatively affecting psychological well-being, cognitive functioning, and overall quality of life. Reduced physical activity during treatment is strongly associated with worsening fatigue, impaired sleep, and decreased quality of life in pediatric oncology patients. However, treatment side effects, prolonged hospitalization, infection risk, and lack of motivating play-based activities often limit children's participation in physical activity during treatment. Recent evidence suggests that physical activity interventions may help reduce fatigue and improve well-being in children with cancer, yet engaging and age-appropriate non-pharmacological interventions remain limited, especially for younger children.

This pilot randomized controlled trial aims to evaluate the feasibility and potential effects of a robot-dog-assisted walking intervention on sleep quality, fatigue, and quality of life among children aged 2-7 years undergoing cancer treatment.

Eligibility criteria

Qualifiers

Aged between 2 and 7 years,

Diagnosed with cancer and currently receiving active treatment,

Pain level not severe enough to interfere with mobilization (FLACC or Wong-Baker FACES score ≤ 4),

Diagnosed within the previous 1 month,

Disqualifiers

Resting SpO₂ <94%, requirement for ≥2 L/min oxygen support, or recurrent desaturation episodes within the last 24 hours,

Heart rate or respiratory rate significantly elevated or irregular for age,

Hemodynamic instability,

Visual, hearing, or severe cognitive impairment that would prevent interaction with the robotic dog,

Trial design

Treatments tested in this trial

  • Robot-Dog-Assisted Walking

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators